Vanguard Global
Vanguard Global Advisers, LLC ownership in PSTV / Plus Therapeutics, Inc. On May 8, 2026 - Vanguard Global Advisers, LLC filed a 13F-HR form disclosing ownership of 57,068 shares of Plus Therapeutics, Inc. (US:PSTV) valued at $9,279 USD as of March 31, 2026. The current value of the position is $339,555 USD